United Capital Financial Advisers, LLC Gsk PLC Transaction History

United Capital Financial Advisers, LLC

$19.9 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$42.05 - $47.77 $267,732 - $304,151	6,367 Added 1.52%	426,024 $18.5 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $462,282 - $548,580	11,491 Added 2.82%	419,657 $18.3 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $485,183 - $565,423	12,479 Added 3.15%	408,166 $18 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $702,370 - $781,498	18,107 Added 4.8%	395,687 $15.1 Million
Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $423,558 - $480,853	11,598 Added 3.17%	377,580 $15 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $863,227 - $1.01 Million	25,189 Added 7.39%	365,982 $13.1 Million
Q4 2020 Feb 17, 2021	BUY	$34.07 - $39.94 $323,903 - $379,709	9,507 Added 2.87%	340,793 $12.5 Million
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $360,520 - $406,685	9,460 Added 2.94%	331,286 $12.5 Million
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $549,077 - $631,866	-14,499 Reduced 4.31%	321,826 $13.1 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $8,864 - $13,330	-273 Reduced 0.08%	336,325 $12.7 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $1.42 Million - $1.63 Million	33,732 Added 11.14%	336,598 $15.8 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $199,184 - $214,248	-4,923 Reduced 1.6%	302,866 $12.9 Million
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $346,759 - $375,802	8,801 Added 2.94%	307,789 $12.3 Million
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $512,479 - $567,222	13,287 Added 4.65%	298,988 $12.5 Million
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $162,766 - $183,823	-4,306 Reduced 1.48%	285,701 $10.9 Million
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $481,889 - $517,530	12,123 Added 4.36%	290,007 $11.7 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $444,820 - $480,194	-11,230 Reduced 3.88%	277,884 $11.2 Million
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $10.5 Million - $11.6 Million	289,114 New	289,114 $11.3 Million
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $10.1 Million - $11.9 Million	-285,172 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $388,957 - $409,766	9,862 Added 3.58%	285,172 $11.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	275,310	275,310 $11.9 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account